SeaStar Medical director awarded 3,000 RSUs

SeaStar Medical Holding Corp director Vincent Bernadette N reported receiving 3,000 shares of common stock on February 6, 2026 under transaction code A, indicating an acquisition.

Accepted by SEC EDGAR 02/10/2026 - 04:57 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

SeaStar Medical Holding Corp director Vincent Bernadette N reported receiving 3,000 shares of common stock on February 6, 2026 under transaction code A, indicating an acquisition. The filing notes this represents a restricted stock unit (RSU) award that will vest in full on February 6, 2027. The shares were acquired at a stated price of $0 per share, leaving the director with 4,200 shares of beneficially owned common stock held directly after the grant.

Insider Trade Summary

Grant/Award: 3,000 shares

Grant/Award 1 txn

Insider Vincent Bernadette N

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, par value $0.0001	3,000	$0.00	$0.00

Holdings After Transaction: Common Stock, par value $0.0001 — 4,200 shares (Direct)

Footnotes (1)

1. F1. Represents a RSU award. The RSUs will vest in full on February 6, 2027.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did SeaStar Medical (ICU) report for Vincent Bernadette N?

SeaStar Medical reported that director Vincent Bernadette N acquired 3,000 shares of common stock as a restricted stock unit award. The RSUs were granted on February 6, 2026, and increased her directly held beneficial ownership to 4,200 shares after the transaction.

How many SeaStar Medical (ICU) shares did the director hold after the RSU award?

After receiving the 3,000-share RSU award, director Vincent Bernadette N beneficially owned 4,200 shares of SeaStar Medical common stock. The ownership is reported as direct, meaning the shares are held in her own name rather than through an intermediary entity.

What are the vesting terms of the RSU award reported by SeaStar Medical (ICU)?

The filing states the 3,000-share grant represents a restricted stock unit award that will vest in full on February 6, 2027. This means the director’s right to the underlying shares becomes fully earned and non-forfeitable on that single vesting date.

At what price were the SeaStar Medical (ICU) RSUs granted to the director?

The Form 4 shows the 3,000 shares of common stock tied to the RSU award at a transaction price of $0 per share. This reflects the nature of equity compensation grants, not an open-market purchase by the director for cash consideration.

Is the SeaStar Medical (ICU) director an officer or 10% owner in this Form 4?

According to the filing, Vincent Bernadette N is reported as a director of SeaStar Medical but not as an officer or 10% owner. The box for director is checked, while the officer and 10% owner designations are not selected in the relationship section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Vincent Bernadette N

(Last) (First) (Middle)

3513 BRIGHTON BLVD

SUITE 410

(Street)

DENVER C0 80216

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SeaStar Medical Holding Corp [ ICU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.0001	02/06/2026		A		3,000(1)	A	$0	4,200	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a RSU award. The RSUs will vest in full on February 6, 2027.

Remarks:

Ex. 24.1 - Power of Attorney

	/s/ Eric Schlorff as-attorney-in-fact	02/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.